Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more / Healthy Returns: AbbVie is the newest potential weight loss drug market player / Beyond the Possible: How AbbVie Uses Technology to Transform Medicines for Patients / Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more / Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up / Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors / AbbVie's newer drugs are offsetting losses of the world's once best-selling medication / Copycats take bite out of AbbVie's best-selling Humira drug / $19 Billion in a Week: AbbVie Makes Two Big Bets / AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion